Cell-free DNA fragmentomics and epigenomic profiling in hematologic malignancies: current evidence, translational limitations, and future directions. // Translational Oncology. – URL: https://www.sciencedirect.com/science/article/pii/S193652332600416X?dgcid=rss_sd_all
Cell-free DNA fragmentomics and epigenomic profiling in hematologic malignancies: current evidence, translational limitations, and future directions. Translational Oncology. https://www.sciencedirect.com/science/article/pii/S193652332600416X?dgcid=rss_sd_all
“Cell-free DNA fragmentomics and epigenomic profiling in hematologic malignancies: current evidence, translational limitations, and future directions.” Translational Oncology.
@article{article91100,
title = {Cell-free DNA fragmentomics and epigenomic profiling in hematologic malignancies: current evidence, translational limitations, and future directions},
journal = {Translational Oncology},
url = {https://www.sciencedirect.com/science/article/pii/S193652332600416X?dgcid=rss_sd_all}
}